Transaction · 0000886982-26-000522

GOLDMAN SACHS GROUP INC

GOLDMAN SACHS GROUP INC, 10%, reported a transaction classified as unknown at Attovia Therapeutics, Inc. involving 18181830.000000 shares for an estimated $0.00. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

unknownSEC transaction code C10%
ATTOAttovia Therapeutics, Inc.
Filing timeAug 28
Trade dateAug 06, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
Pre-filing
Returns since

ATTO price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ATTO since 2026-08-28Filed 6 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
unknown
Code C
Identifier
0000886982-26-000522
Series B Preferred Stock
Transaction date
Aug 06, 2026
Filed Aug 28, 2026, 09:38 PM · 22d delay
Shares
18.1M sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
0 sh
Indirect · See footnotes

Filing warnings

Notes recorded with this filing
2 warnings
amended filingThis transaction comes from an amended Form 4 filing.
delayed filingThe filing was reported 22 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Amended Filing Delayed Filing Derivative Transaction
-28score
Filing-only score

-28

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector No10% NoOther Yes
Footnotes & amended
  1. F1

    Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an ad…

  2. F2

    These transactions in or with respect to the common stock of the Issuer were effected by Goldman Sachs & Co. LLC ("GS&Co") acting as a market maker in the ordinary course of business. Without concedin…

  3. F3

    GS&Co's transactions in or with respect to the Issuer's common stock on August 5, 2026 consisted of purchases of a total of 85,000 shares, sales of a total of 105,807 shares, and establishment of long…

  4. F4

    The previous report on Form 3 reflected an administrative error with respect to the number of shares of common stock issuable upon conversion of the Preferred Stock, which is corrected in this Form 4.…

  5. F5

    All shares of the Issuer's redeemable convertible preferred stock automatically converted into shares of the Issuer's common stock on a 1-for-1 basis, adjusted for a 1-for-9.29 reverse stock split eff…

  6. F6

    This statement is being filed by Goldman Sachs Group, Inc. ("GS Group"), GS&Co, Goldman Sachs Asset Management, L.P. ("GSAM LP"), Broad Street Principal Investments L.L.C. ("BSPI"), which directly hol…

  7. F7

    (continued from footnote 6)...WSLS Emp Offshore Investments, L.P. ("WSLS Emp Offshore"), which directly holds 36,927 shares of common stock purchased in the IPO and 179,879 shares of common stock conv…

Amended filing · 0000886982-26-000522
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ATTO